Reuters logo
BRIEF-Entasis announces $31.9 mln extension of Series B financing to advance anti-infective therapeutic portfolio
September 5, 2017 / 12:22 PM / in 2 months

BRIEF-Entasis announces $31.9 mln extension of Series B financing to advance anti-infective therapeutic portfolio

Sept 5 (Reuters) -

* Entasis announces $31.9 million extension of Series B financing to advance anti-infective therapeutic portfolio

* Entasis - Series B-1 funding will support company’s programs to treat multidrug-resistant Gram-negative infections Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below